Page 4 - சிங்கப்பூர் தேமாஸேக் ஹோல்டிங்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Synopsis True North, the private equity fund which owns Integrace, will sell about 25-30% stake to the potential investor, multiple people aware of the development, said. Getty Images A clutch of private equity funds Singapore’s Temasek Holdings, Kuala Lumpur’s Creador and homegrown Kedaara Capital are in separate talks to acquire a significant minority stake in Integrace, the Mumbai-based pharmaceutical formulations manufacturer to tap the rising potential of the Indian drug industry. True North, the private equity fund which owns Integrace, will sell about 25-30% stake to the potential investor, multiple people aware of the development, said. The deal is likely to value Integrace at ₹1,300-1,400 crore, said one of the sources. Investment bank Rothschild advises True North in the stake sale.

Kedar rajadnyeKuala lumpur creadorParas pharmaGlobal health medantaIntas pharmaceuticalsSingapore temasek holdingsSyngene internationalTemasek holdingsKuala lumpurKedaara capitalTrue northGlobal healthபராஸ் பார்மாஇன்டாஸ் மருந்துகள்சிங்கப்பூர் தேமாஸேக் ஹோல்டிங்ஸ்தேமாஸேக் ஹோல்டிங்ஸ்